Shares of Oncolytics Biotech Inc. (TSE:ONC - Get Free Report) were up 24.1% during trading on Wednesday . The company traded as high as C$1.72 and last traded at C$1.70. Approximately 892,106 shares traded hands during mid-day trading, an increase of 556% from the average daily volume of 135,968 shares. The stock had previously closed at C$1.37.
Analysts Set New Price Targets
Separately, Jones Trading downgraded shares of Oncolytics Biotech from a "strong-buy" rating to a "hold" rating in a research note on Friday, May 16th.
Get Our Latest Research Report on Oncolytics Biotech
Oncolytics Biotech Price Performance
The company has a debt-to-equity ratio of 11.75, a quick ratio of 8.86 and a current ratio of 2.99. The business's 50 day simple moving average is C$0.82 and its 200-day simple moving average is C$0.94. The stock has a market capitalization of C$123.32 million, a price-to-earnings ratio of -4.46 and a beta of 1.35.
About Oncolytics Biotech
(
Get Free Report)
Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.
Recommended Stories
Before you consider Oncolytics Biotech, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oncolytics Biotech wasn't on the list.
While Oncolytics Biotech currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
